MedTrace Logo

Adult ALL Treatment at Diagnosis

NCT00537550 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-10-01

No results posted yet for this study

Summary

The present study has been designed to give participating centers the possibility of better understanding the diagnostic and prognostic factors of ALL patients.

Conditions

  • Leukemia, Lymphocytic, Acute

Interventions

DRUG

Vincristine

Steroids pre-treatment

DRUG

Vincristin, Daunorubicine, Asparaginase, Methotrexate

Induction therapy

Sponsors & Collaborators

  • Gruppo Italiano Malattie EMatologiche dell'Adulto

    lead OTHER

Principal Investigators

  • Franco MANDELLI, Pr · Università degli Studi di Roma "La Sapienza"

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-07-31
Completion
2006-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00537550 on ClinicalTrials.gov